NEUROLOGICAL DISEASES, NEUROSCIENCE & MENTAL HEALTH

Genetic Diseases

Main lines of research

  • Study of the clinical heterogeneity of genetic autosomal recessive transmission of waist dystrophy and autosomal dominant transmission.
  • Spinal atrophy and SMN genes: 1.- studies of molecular pathology, disease mechanisms and SMN gene expression. 2.- Identification of modifying genes. 3.- study of biomarkers for validation processing in spinal muscular atrophy. 4.- study of the neuromuscular junction in human development.
  • Hereditary breast cancer and BRCA mutations: 1. Identification of mutations and genetic variants. 2. Molecular characterization of Circulating tumor cells (CTCSS) through expression profiles in patients with f breast cancer. 3. Analysis of free circulating tumor DNA (cfDNA) as a predictor of response to the treatment of breast cancer.
  • Pharmacogenetics: adverse reactions to medications.
  • Congenital coagulopathies: Molecular Pathology of haemophilias.
  • Duchenne and Becker muscular dystrophy: molecular pathology of DMD gene.

Challenges

Pharmacogenetics

  • Colorectal and lung cancer treatments.
  • Chronic inflammatory disease treatment.
  • HIV infection treatment.

Muscular Distrophies

  • Post-transcriptional regulation of the dystrophin gene using nonsense-mediated decay analysis in DNA from patients with Duchenne muscular dystrophy.
  • Genes associated with new phenotypic forms of limb girdle muscular dystrophy.
  • Workflow development for the analysis of DMD gene by NGS techniques.

Hereditary Breast/Ovarian Cancer

  • DNA studies to classify DNA variants found in the BRCAs genes as pathogenic or neutral.
  • CTCs as prognostic markers in patients with locally advanced and disseminated breast cancer.
  • Workflow development for the analysis of BRCA1 and BRCA2 genes by NGS techniques.

Hereditary Motor Neurone Diseases

  • Development of neuromuscular junction studies in health and disease.
  • Broadening of the spectrum of motor neuron diseases to include bulbar and spinal muscular atrophy, distal muscular atrophies and amyotrophic lateral sclerosis.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information